New Delhi, Delhi, 6th of February, 2025 : Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), a leading institution in cancer care and research organized a special vaccination camp in association with Children Unbound Foundation and Salcomp to mark World Cancer Day 2025. As part of the event, 150 girls aged 15–20 years were administered free doses of the human papillomavirus (HPV) vaccine, ensuring protection against high-risk HPV types that are known to cause cervical cancer.
The initiative aimed to promote HPV vaccination as a primary preventive measure against cervical cancer.
Speaking about the initiative, Indu Aggarwal, Head of Department, Preventive Oncology, RGCIRC, said, “While many cancers, including cervical cancer, are preventable, the challenge lies in raising awareness and improving access to care. Through the ongoing vaccination drive, we aim to reach the young population, offering hope and prevention to curb the rising cancer burden in India.”
The vaccination drive kicked off with a symbolic lamp-lighting ceremony marking the beginning of a day focused on raising awareness and promoting preventive health measures. Following the lamp-lighting ceremony, an awareness skit/play was performed, emphasizing the importance of HPV vaccination in preventing cervical cancer and educating the audience about the significance of early prevention and health screenings.
Dr. Shashi Rakheja, Senior Consultant, Preventive Oncology, RGCIRC emphasized, “ Vaccinating at a young age is crucial as it provides immunity before exposure to high-risk HPV strains, significantly lowering the risk of cervical cancer. The WHO aims to have 90% of girls vaccinated by their 15th birthday by 2030. It’s crucial that we raise awareness, educate communities, and promote screening and vaccination to protect future generations from this preventable cancer.”
The vaccination drive was conducted with in association with Salcomp & Children Unbound Foundation. The initiative witnessed enthusiastic participation, reinforcing RGCIRC’s commitment to cancer prevention, public health awareness, and community well-being. Through such efforts, the institute continues to contribute toward the larger goal of eradicating cervical cancer in alignment with WHO’s 2030 strategy.
About RGCIRC:
Established in 1996, Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) is counted among Asia’s premier exclusive cancer centres offering the unique advantage of cutting-edge technology, and expertise provided by super specialists. Spread over nearly 2 Lakh square feet area, with a current capacity of 500+ beds at Rohini along with another unit at Niti Bagh, RGCIRC is one of the largest tertiary cancer care centres in the continent. With a track record of serving more than 3.5 Lakh patients, the institute offers best-in-class techniques such as whole-body robotic surgery, Cyber Knife, Tomotherapy, True Beam (the next generation Image Guided Radiation Therapy), Intra-Operative Brachytherapy, PET- MRI fusion, and many more. RGCIRC has 14 state-of-the-art well equipped modular Operation Theatres with three-stage air filtration and gas scavenging systems, and 3 Minor Operation Theatres for Day Care Surgeries. RGCIRC has been consistently ranked amongst India’s Best Oncology Hospitals and has been the recipient of many awards. In 2024, The Newsweek International- one of the renowned American Magazines, has ranked RGCIRC as one of the Best Specialized Hospitals in Asia Pacific 2024 and also World’s Best Specialized Hospitals, 2025.
About The Author
More Stories
Union Minister Dr Mansukh Mandaviya Leads Fit India Sundays On Cycle Event In Ahmedabad; Guinness World Record Holder Rohtash Chaudhary Joins From Delhi.
Prime Minister Condoles Demise Of Shri Ramakanta Rath.
India – New Zealand Announce Launch Of FTA Negotiations.